Monitoring gene expression of TNFR family members by β-cells during development of autoimmune diabetes

European Journal of Immunology

Volumn 30, Issue 4, 2000, Pages 1224-1232

  Walter, Ulrich ^a   Frantzke, Anke ^a   Sarukhan, Adelaida ^a   Zober, Carole ^a   Von Boehmer, Harald ^a,c   Buer, Jan ^b   Lechner, Oskar ^a  

^a INSERM   (France)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

cell; Diabetes; NOD mouse; TCR HA x INS HA mouse; TNF receptor family

Indexed keywords

CELL SURFACE RECEPTOR; FAS ANTIGEN; HEMAGGLUTININ; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSGENE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; CELL LINE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, TRANSGENIC; MULTIGENE FAMILY; PEPTIDE FRAGMENTS; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033995129     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200004)30:4<1224::AID-IMMU1224>3.0.CO;2-B     Document Type: Article

References (48)

1. Bach, J. F., Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Res. 1994. 15: 516-542.
2. Tarn, A. C., Thomas, J, M., Dean, B. M., Ingram, D., Schwarz, G., Bottazzo, G. F. and Gale, E. A., Predicting insulin-dependent diabetes. Lancet 1988. 1: 845-850.
3. Vyse, T. J. and Todd, J. A., Genetic analysis of autoimmune disease. Cell 1996. 85: 311-318.
4. Kurrer, M. O., Pakala, S. V., Hanson, H. L. and Katz, J. D., Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1997. 94: 213-218.
5. Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H. and Flavell, R. A., Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct pattern of inflammation in TNF-alpha and TNF-beta transgenic mice. J. Immunol. 1993. 150: 4136-4150.
6. Kikutani, H. and Makino, S., The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 1992. 51: 285-322.
7. Tochino, Y., The NOD mouse as a model of type I diabetes. Crit. Rev. Immunol. 1987. 8: 49-81.
8. Bendelac, A., Carnaud, C., Boitard, C. and Bach, J. F., Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J. Exp. Med. 1987. 166: 823-832.
9. Wicker, L. S., Miller, B. J. and Mullen, Y., Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986. 35: 855-860.
10. Prochazka, M., Gaskins, H. R., Shultz, L. D. and Leiter, E. H., The nonobese diabetic scid mouse: model for spontaneous thymomagnesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 1992. 89: 3290-3294.
11. Peterson, J. D. and Haskins, K., Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 1996. 45: 328-336.
12. Soderstrom, I., Bergman, M. L., Colucci, F., Lejon, K., Bergqvist, I. and Holmberg, D., Establishment and characterization of RAG-2 deficient non-obese diabetic mice. Scand. J. Immunol. 1996. 43: 525-530.
13. Wong, F. S. and Janeway, C. A., Jr., The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse. Res. Immunol. 1997. 148: 327-332.
14. Kagi, D., Odermatt, B., Seiler, P., Zinkernagel, R. M., Mak, T. W. and Hengartner, H., Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 1997. 186: 989-997.
15. Amrani, A., Verdaguer, J., Anderson, B., Utsugi, T., Bou, S. and Santamaria, P., Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. J. Clin. Invest. 1999. 103: 1201-1209.
16. Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M. and Hengartner, H., Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991. 65: 305-317.
17. von Herrath, M. G., Efrat, S., Oldstone, M. B. and Horwitz, M. S., Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1997. 94: 9808-9813.
18. Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O. and Lo, D., A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994. 1: 73-83.
19. Harlan, D. M., Hengartner, H., Huang, M. L., Kang, Y. H., Abe, R., Moreadith, R. W., Pircher, H., Gray, G. S., Ohashi, P. S. and Freeman, G. J., Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl. Acad. Sci. USA 1994. 91: 3137-3141.
20. Soldevila, G., Geiger, T. and Flavell, R. A., Breaking immunologie ignorance to an antigenic peptide of simian virus 40 large T antigen. J. Immunol. 1995. 155: 5590-5600.
21. Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F. and Kosaka, H., Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 1996. 184: 923-930.
22. Sarukhan, A., Lanoue, A., Franzke, A., Brousse, N., Buer, J. and von Boehmer, H., Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model. EMBO J. 1998. 17: 71-80.
23. Morgan, D. J., Liblau, R., Scott, B., Fleck, S., McDevitt, H. O., Sarvetnick, N., Lo, D. and Sherman, L. A., CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 1996. 157: 978-983.
24. Roman, L. M., Simons, L. F., Hammer, R. E., Sambrook, J. F. and Gething, M. J., The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 1990. 61: 383-396.
25. Kagi, D., Odermatt, B., Ohashi, P. S., Zinkernagel, R. M. and Hengartner, H., Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 1996. 183: 2143-2152.
26. LaFace, D. M. and Peck, A. B., Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. Diabetes 1989. 38: 894-901.
27. Lo, D., Reilly, C. R., Scott, B., Liblau, R., McDevitt, H. O. and Burkly, L. C., Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur. J. Immunol. 1993. 23: 1693-1698.
28. Sarukhan, A., Lechner, O. and von Boehmer, H., Autoimmune insulitis and diabetes in the absence of antigen specific contact between T cells and β-islet cells. Eur. J. Immunol. 1999. 29: 3410-3416.
29. Pakala, S. V., Chivetta, M., Kelly, C. B. and Katz, J. D., In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J. Exp. Med. 1999. 189: 1053-1062.
30. Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A., Jr. and Matis, L. A., The role of Fas in autoimmune diabetes. Cell 1997. 89: 17-24.
31. Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K., Iwahashi, H., Moriwaki, M., Nakajima, H., Miyagawa, J., Namba, M., Makino, S., Nagata, S., Kono, N. and Matsuzawa, Y., Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 1997. 186: 613-618.
32. Kim, Y. H., Kim, S., Kim, K. A., Yagita, H., Kayagaki, N., Kim, K. W. and Lee, M. S., Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur. J. Immunol. 1999. 29: 455-465.
33. Allison, J. and Strasser, A., Mechanisms of beta cell death in diabetes: a minor role for CD95. Proc. Natl. Acad. Sci. USA 1998. 95: 13818-13822.
34. McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., McCarthy, J., Frucht, D. M., Aringer, M., Torosyan, Y., Teppo, A. M., Wilson, M., Karaarslan, H. M., Wan, Y., Todd, I., Wood, G., Schlimgen, R., Kumarajeewa, T. R., Cooper, S. M., Vella, J. P. and Kastner, D. L., Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999. 97: 133-144.
35. Pipeleers, D., Islet cell interactions with pancreatic β-cells. Experientia 1984. 40: 1114-1126.
36. Ling, Z., Hannaert, J. C. and Pipeleers, D., Effect of nutrients, hormones and serum on survival of rat islet beta cells in culture. Diabetologia 1994. 37: 15-21.
37. Bradley, B. J., Haskins, K., La Rosa, F. G. and Lafferty, K. J., CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes 1992. 41: 1603-1608.
38. Katz, J. D., Benoist, C. and Mathis, D., T helper cell subsets in insulin-dependent diabetes. Science 1995. 268: 1185-1188.
39. Bendtzen, K., Buschard, K., Diamant, M., Horn, T. and Svenson, M., Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid diseases. Thyroid Cell Group. Lymphokine Res. 1989. 8: 335-340.
40. Madrup-Poulsen, T., Bendtzen, K., Dinarello, C. A. and Nerup, J., Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J. Immunol. 1987. 139: 4077-4082.
41. Boehm, U., Klamp, T., Groot, M. and Howard, J. C., Cellular response to interferon-gamma. Annu. Rev. Immunol. 1997. 15: 749-795.
42. Hultgren, B., Huang, X., Dybdal, N. and Stewart, T. A., Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996. 45: 812-817.
43. von Herrath, M. G. and Oldstone, M. B., Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 1997. 185: 531-539.
44. Kagi, D., Ho, A., Odermatt, B., Zakarian, A., Ohashi, P. S. and Mak, T. W., TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J. Immunol. 1999. 162: 4598-4605.
45. Kirberg, J., Baron, A., Jakob, S., Rolink, A., Karjalainen, K. and von Boehmer, H., Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 1994. 180: 25-34.
46. Faveeuw, C., Gagnerault, M. C. and Lepault, F., Isolation of leukocytes infiltrating the islets of Langerhans of diabetes-prone mice for flow cytometric analysis. J. Immunol Methods 1995. 187: 163-169.
47. Groettrup, M., Ungewiss, K., Azogui, O., Palacios, R., Owen, M. J., Hayday, A. C. and von Boehmer, H., A novel disulfidlinked heterodimer on pre-T cells consists of the T cell receptor beta chain and a 33 kd glycoprotein. Cell 1993. 75: 283-294.
48. Engler, P. and Storb, U., High-frequency deletional rearrangement of immunoglobulin kappa gene segments introduced into a pre-B-cell line. Proc. Natl. Acad. Sci. USA 1987. 84: 4949-4953.